Further research needs to be conducted in order to understand this paradox, controlling for the expression of PD-L1 in other cell types including cancer cells, other myeloid cells like macrophages and dendritic cells, and stromal cells, as well as the molecular and immune subtype classification of the tumour, which is known to predict immune checkpoint inhibition response. The gene discussed is CD274; the disease is neoplasm.